NCT07688109

Brief Summary

The goal of this clinical trial is to compare primary wound closure (PC) versus delayed primary closure (DPC) after standardized wound decontamination using the High-Efficiency Incision and Drainage with Irrigation (HIEDI) technique in patients undergoing open appendectomy for complicated appendicitis in Sana'a, Yemen. The main questions it aims to answer are:

  • Does primary closure with HIEDI result in a non-inferior or lower incidence of Surgical Site Infection (SSI) at 30 days compared with delayed primary closure with HIEDI?
  • Does primary closure with HIEDI reduce length of hospital stay and improve the trajectory of objective wound healing compared with delayed primary closure with HIEDI?
  • What is the impact of each closure method on patient satisfaction and health-related quality of life? Researchers will compare the two groups to determine the optimal, evidence-based standard of care for wound management in complicated appendicitis within a resource-limited setting. Participants will:
  • Undergo open appendectomy for intraoperatively confirmed complicated appendicitis (perforation or gangrene).
  • Receive standardized HIEDI wound decontamination (meticulous debridement and pulsatile irrigation with minimum 500 mL povidone-iodine 1:10 solution).
  • Be randomly allocated to either primary closure (all layers closed at surgery) or delayed primary closure (skin/subcutaneous tissue left open and closed 3-5 days later).
  • Attend follow-up visits at days 7, 14, and 30 for wound assessment, infection surveillance, and outcome evaluation.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Jul 2026Nov 2026

First Submitted

Initial submission to the registry

June 27, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 7, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

July 7, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

June 27, 2026

Last Update Submit

July 2, 2026

Conditions

Keywords

Complicated appendicitisPrimary wound closureDelayed primary closureSurgical Site InfectionHIEDI techniqueWound decontaminationAppendectomyYemenRandomized controlled trialHigh-Efficiency Incision and Drainage with Irrigation

Outcome Measures

Primary Outcomes (1)

  • Incidence of Surgical Site Infection (SSI) at 30 Days

    Surgical Site Infection (SSI) diagnosed according to Centers for Disease Control and Prevention (CDC) criteria, classified as superficial incisional, deep incisional, or organ/space infection. Assessed by trained outcome assessors blinded to treatment allocation.

    Up to 30 days postoperatively

Secondary Outcomes (5)

  • Objective Wound Healing Trajectory (ASEPSIS Score)

    Day 7, Day 14, and Day 30 postoperatively

  • Length of Hospital Stay (days)

    From admission to discharge, assessed up to 30 days

  • Incidence of Other Postoperative Complications

    Up to 30 days postoperatively

  • Patient Satisfaction Score (0-100 scale)

    Day 7, Day 14, Day 30

  • Health-Related Quality of Life (EQ-5D-5L score)

    Day 7, Day 14, Day 30

Study Arms (2)

Primary Closure with HIEDI

EXPERIMENTAL

Participants undergo open appendectomy for complicated appendicitis followed by the High-Efficiency Incision and Drainage with Irrigation (HIEDI) protocol. All wound layers including skin are closed at the time of initial surgery using the Primary Closure (PC) technique. Target enrollment: 100 participants.

Procedure: Primary Closure with HIEDI

Delayed Primary Closure with HIEDI

ACTIVE COMPARATOR

Participants undergo open appendectomy for complicated appendicitis followed by the High-Efficiency Incision and Drainage with Irrigation (HIEDI) protocol. Deep fascial layers are closed; subcutaneous tissue and skin are left open, packed with saline-soaked gauze, and closed at the bedside 3-5 days postoperatively if no infection signs are present using the Delayed Primary Closure (DPC) technique. Target enrollment: 100 participants.

Procedure: Delayed Primary Closure with HIEDI

Interventions

Following open appendectomy for complicated appendicitis, the surgical wound undergoes the High-Efficiency Incision and Drainage with Irrigation (HIEDI) protocol: meticulous debridement of wound edges and pulsatile high-pressure irrigation with a minimum of 500 mL of povidone-iodine solution (1:10 dilution). All layers of the surgical wound, including the skin, are closed at the time of the initial surgery using standard techniques.

Primary Closure with HIEDI

Following open appendectomy for complicated appendicitis, the surgical wound undergoes the High-Efficiency Incision and Drainage with Irrigation (HIEDI) protocol: meticulous debridement of wound edges and pulsatile high-pressure irrigation with a minimum of 500 mL of povidone-iodine solution (1:10 dilution). The deep fascial layers are closed; the subcutaneous tissue and skin are left open, packed with saline-soaked gauze, and covered. The wound is closed at the bedside 3-5 days postoperatively if no signs of infection are present.

Delayed Primary Closure with HIEDI

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 12 years and older
  • Intraoperative diagnosis of complicated appendicitis (perforation or gangrene)
  • Undergoing open appendectomy via McBurney or Rocky-Davis incision
  • Ability to provide written informed consent (patient or legal guardian for minors)
  • Availability for 30-day follow-up

You may not qualify if:

  • Generalized peritonitis requiring midline laparotomy
  • Immunocompromised status (e.g., chronic corticosteroid or immunosuppressive therapy, diagnosed HIV infection)
  • Poorly controlled diabetes mellitus (Hemoglobin A1c \[HbA1c\] greater than 8%)
  • Pregnancy
  • Concurrent malignancy
  • American Society of Anesthesiologists (ASA) physical status classification IV or V
  • Laparoscopic appendectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Al-Gumhori Teaching Hospital

Sanaa, Yemen

Location

Al-Kuwaint University Hospital

Sanaa, Yemen

Location

Al-Thawra Modern General Hospital

Sanaa, Yemen

Location

MeSH Terms

Conditions

AppendicitisSurgical Wound InfectionPostoperative Complications

Condition Hierarchy (Ancestors)

Intraabdominal InfectionsInfectionsGastroenteritisGastrointestinal DiseasesDigestive System DiseasesCecal DiseasesIntestinal DiseasesWound InfectionPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Dr. Yasser Abdurabo Obadiel, Associate Professor

    Faculty of Medicine and Health Sciences, Sana'a University

    STUDY DIRECTOR

Central Study Contacts

Dr. Abdulla Salem Faraj, M.D.

CONTACT

Dr. Yasser Abdurabo Obadiel, Associate Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Due to the visible nature of the surgical interventions, blinding of surgeons and patients is not feasible. Outcome assessors evaluating Surgical Site Infection (SSI), data analysts, and laboratory personnel processing wound cultures are blinded to treatment allocation. Group assignments are coded as Group A and Group B until primary analysis is complete.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, multicenter, parallel-group, 1:1 randomized controlled superiority trial. Computer-generated block randomization (variable block sizes 4, 6, 8) stratified by hospital site. Allocation concealment via sequentially numbered, opaque, sealed envelopes (SNOSE) opened in the operating room only after intraoperative confirmation of eligibility and informed consent.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

June 27, 2026

First Posted

July 7, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

July 7, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

The study team does not plan to share individual participant data with other researchers. This is a single-center thesis study with limited data management infrastructure, and the dataset contains identifiable clinical information that cannot be sufficiently de-identified for broad sharing under local ethical guidelines.

Locations